• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Horizon Therapeutics (NQ: HZNP )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 116.33 (2)
    Ask (Size) 116.37 (25)
    Prev. Close 116.30
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 228,994,568
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Stocks to Buy Low Today With High Hopes for Tomorrow
    Amgen, Canadian Solar, and Diana Shipping are three undervalued stocks with high potential for growth that can enhance portfolio returns. 
    Via InvestorPlace
    Rule 17(e) Announcement - Horizon Therapeutics plc
    From Horizon Therapeutics plc
    Via Business Wire

    Performance

    More News

    Read More
    Peering Into Horizon Therapeutics's Recent Short Interest
    Via Benzinga
    Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High
    Via Investor Brand Network
    Rule 17(d) Announcement – Horizon Therapeutics plc
    From Horizon Therapeutics plc
    Via Business Wire
    Here's How Much $100 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth Today
    Via Benzinga
    Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High
    Via Investor Brand Network
    How Is The Market Feeling About Horizon Therapeutics?
    Via Benzinga
    $1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth This Much Today
    Via Benzinga
    Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    From Horizon Therapeutics plc
    Via Business Wire
    Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    From Horizon Therapeutics plc
    Via Business Wire
    Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
    From Horizon Therapeutics plc
    Via Business Wire
    Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    From Horizon Therapeutics plc
    Via Business Wire
    New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes
    From Horizon Therapeutics plc
    Via Business Wire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    From Horizon Therapeutics plc
    Via Business Wire
    Horizon Therapeutics PLC (NASDAQ: HZNP) Sets New 52-Week High in Tuesday Session
    Via Investor Brand Network
    Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry
    From Horizon Therapeutics plc
    Via Business Wire
    Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    From Horizon Therapeutics plc
    Via Business Wire
    Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List
    From Horizon Therapeutics plc
    Via Business Wire
    Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata
    From Horizon Therapeutics plc
    Via Business Wire
    These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
    Via Benzinga
    The 3 Most Undervalued Biotech Stocks to Buy in September 2023
    Via InvestorPlace
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Horizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement
    From Horizon Therapeutics plc
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.